Precision medicine through polymathic AI
Find out more
OUR APPROACH
We are a science-first company hacking the genetic vulnerability of brain disease
We combine hyperscale proprietary data with custom-built biology and chemistry foundation models. By digitising cellular responses to perturbation, we can represent biology at higher levels of abstraction and train models that understand multiple layers of systems biology and chemistry. We call this multi-modal understanding “Polymathic AI”. This enables us to rapidly discover drugs that target the exact molecular features of a particular patient’s disease.
Our Purpose
Our VISIOn
We believe the precision medicine we build today will become the personalised medicine of tomorrow.
Our team
We are a group of scientific and imaginative minds united around a common mission
Magic happens when mathematicians, biologists, chemists, engineers, physicists, medics and AI scientists work together on the same problem.
Investors
CoSyne Therapeutics is backed by investors with expertise in technology and life sciences.
